Characterization of human homeodomain-interacting protein kinase 4 (HIPK4) as a unique member of the HIPK family

Molecular and Cellular Pharmacology

Volumn 2, Issue 2, 2010, Pages 61-68

  He, Qin ^a   Shi, Jingxue ^a   Sun, Hong ^a   An, Jie ^a   Huang, Ying ^a   Sheikh, M Saeed ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

HIPK family; HIPK4; Kinase; Phosphorylation; Site directed mutagenesis; Sumoylation

Indexed keywords

ASPARTIC ACID; HOMEODOMAIN INTERACTING PROTEIN KINASE 1; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; HOMEODOMAIN INTERACTING PROTEIN KINASE 3; HOMEODOMAIN INTERACTING PROTEIN KINASE 4; LYSINE; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROCESSING; PROTEOMICS; SEQUENCE HOMOLOGY; SUMOYLATION;

EID: 77953449809     PISSN: None     EISSN: 19381247     Source Type: Journal    
DOI: 10.4255/mcpharmacol.10.09     Document Type: Article

References (28)

1. Kim YH, Choi CY, Lee SJ, et al. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 1998;2:273:25875-79.
2. Rinaldo C, Siepi F, Prodosmo A, et al. HIPKs: Jack of all trades in basic nuclear activities. Biochem Biophysica Acta 2008;2124-29.
3. D'Orazi G, Cecchinelli B, Bruno T, et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002;4:11-9.
4. Hofmann TG, Möller A, Sirma H, et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002; 4:1-10.
5. Rochat-Steiner V, Becker K, Micheau O, et al. FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation. J Exp Med 2000;192:1165-74.
6. Sun H, Luo X, Montalbano J, et al. DOC45, a novel DNA damage-regulated nucleocytoplasmic ATPase that is overexpressed in multiple human malignancies. Mol Cancer Res 2010;8:57-66.
7. Montalbano J, Lui K, Sheikh MS, et al. Identification and characterization of RBEL1 subfamily of GTPases in the Ras superfamily involved in cell growth regulation. J Biol Chem 2009;284:18129-42.
8. Corcoran CA, He Q, Ponnusamy S, et al. Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies. Mol Cancer Res 2008;6:795-807.
9. Luo X, He Q, Huang Y, Sheikh MS. Cloning and characterization of a p53 and DNA damage down-regulated gene PIQ that codes for a novel calmodulin-binding IQ motif and is upregulated in gastrointestinal cancers. Cancer Res 2005;65:10725-33.
10. Luo X, Huang Y, Sheikh MS. Cloning and characterization of a novel gene PDRG that is differentially regulated by p53 and ultraviolet radiation. Oncogene 2003;22:7247-57.
11. He Q, Luo X, Jin W, Huang Y, et al. Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP. Oncogene 2008;27:2656-60.
12. Rong R, Jiang LY, Sheikh MS, Huang Y. Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation. Oncogene 2007;26:7700-8.
13. He Q, Shi J, Jones S, et al. Smac deficiency affects endoplasmic reticulum stress-induced apoptosis in human colon cancer cells. Mol Cell Pharmacol 2009;1:23-28.
14. Shi J, He Q, An J, Sun H, Huang Y, Sheikh MS. Sulindac sulfide differentially induces apoptosis in Smacproficient and -deficient human colon cancer cells. Mol Cell Pharmacol 2009;1:92-97.
15. Melchior, F. SUMO--nonclassical ubiquitin. Annu Rev Cell Dev Biol. 2000;16:591-626.
16. Ecsedy JA, Michaelson JS, Leder P. Homeodomain-interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity. Mol Cell Biol 2003;23:950-60.
17. Li X, Zhang R, Luo D, et al. Tumor necrosis factor alpha-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1 are critical for apoptosis signal-regulating kinase 1-JNK/p38 activation. J Biol Chem 2005;280:15061-70.
18. Arai S, Matsushita A, Du K, Yagi K, Okazaki Y, Kurokawa R. Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9. FEBS Lett 2007;581:5649-57.
19. Sheikh MS, Fornace AJ Jr. Role of p53 family members in apoptosis. J Cell Physiol 2000;182:171-81.
20. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007;8:275-283.
21. Higashimoto Y, Saito S, Tong XH, et al. Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J Biol Chem 2000;275:23199-203.
22. Saito S, Goodarzi AA, Higashimoto Y, et al. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J Biol Chem 2002;277:12491-4.
23. Lavin MF, Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ 2006;13:941-50.
24. Sombroek D, Hofmann TG. How cells switch HIPK2 on and off. Cell Death Differ 2009;16:187-94.
25. Isono K, Nemoto K, Li Y, et al. Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol Cell Biol 2006;26:2758-71.
26. Hofmann TG, Jaffray E, Stollberg N, Hay RT, Will H. Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification. J Biol Chem 2005;280:29224-32.
27. Gresko E, Möller A, Roscic A, Schmitz ML. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability. Biochem Biophys Res Commun 2005;329:1293-9.
28. Engelhardt OG, Boutell C, Orr A, Ullrich E, Haller O, Everett RD. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. Exp Cell Res 2003;283:36-50.